ATS Medical Announces First Use of the New ATS CryoMaze 10-S Probe

MINNEAPOLIS, July 20 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first commercial use of the new ATS CryoMaze(TM) 10-S Surgical Cryoablation Probe for the treatment...

ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band

MINNEAPOLIS, July 6 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced FDA clearance and the first implant of the ATS Simulus(R) Semi-Rigid Annuloplasty Band. The Simulus Semi-Rigid Ann...

Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference

CPF Recognized for Advancing Research and Patient Advocacy Efforts SAN DIEGO, May 18 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) today announced awards received at the American Thoracic Society's (ATS) International conference in San Diego, Calif. being held this wee...

ATS Medical Announces FDA Clearance of the ATS Simulus Adjustable Annuloplasty Band

Expands Heart Valve Repair Product Portfolio MINNEAPOLIS, May 12 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced FDA clearance of the ATS Simulus(R) Adjustable Annuloplasty Band...

Pivotal Data on Bronchial Thermoplasty from the Asthma Intervention Research 2 (AIR2) Trial to be Presented at ATS 2009

New non-drug procedure for severe asthma featured in eight presentations at annual conference in San Diego SUNNYVALE, Calif., May 6 /PRNewswire/ -- Asthmatx released today the schedule of presentations featuring its novel Alair(R) Bronchial Thermoplasty System at ATS 2009, the Internation...

ATS Medical Announces Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve in Japan

MINNEAPOLIS, April 16 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the Japanese Ministry of Health, Labor and Welfare has approved commercial distribution of the ATS Open Pivot(R)...

ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Feb. 5 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced today that the Australian Therapeutic Goods Administration (TGA) has granted approval for commercialization of the A...

ATS Medical Announces First Commercial Implants of the ATS 3f Aortic Bioprosthesis in the United States

MINNEAPOLIS, Nov. 24 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that the first three commercial implants of the ATS 3f(R) Aortic Bioprosthesis were completed by Dr. Allan Stewar...

ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Oct. 30 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received U.S. Food and Drug Administration (FDA) approval for the ATS 3f(R) Aortic Bioprosthesis. (Lo...

Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008

- Data demonstrates safety and efficacy of first FDA-approved nebulized formoterol fumarate in patients with moderate to severe COPD - NAPA, Calif., May 16 /PRNewswire/ -- Dey, L.P. announced today that three clinical data presentations will be given at the International Conference of the ...

More>>

ATS in Medical Technology

ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line

Greater than 90% Success Rate at Six-Month Follow-up of 57 Patients MINNEAPOLIS, Feb. 22 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products, today announced initial clinical results of stand-alone ablation proc...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

Positive Results Based on New DSCG Formulation & eFlow Technology Delivery MUNICH and MONTEREY, Calif., May 20 /PRNewswire/ -- This week, Swiss researchers presented positive data from an ongoing Phase II clinical study at the American Thoracic Society (ATS) International Conference that ...

Clinical Trial Data for Perforomist Inhalation Solution to be Presented at ATS on May 20, 2007

-- Data from Phase III pivotal trial demonstrate safety and efficacy of first FDA-approved nebulized formoterol fumarate for patients with moderate to severe COPD -- NAPA, Calif., May 16, 2007 /PRNewswire/ -- Dey, L.P. announced that two clinical data presentations will be given at the Internation...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile -- NAPA, ...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile -- NAPA...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

...DDITIONAL EXPLORATORY EFFICACY RESULTS REPORTED AT ats The ats presentation highlighted new efficacy data from CA... a descriptive fashion. Dr. Noble reported at the ats meeting data on the low-dose pirfenidone group for...

Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma

... Non-drug Procedure for Asthma Highlighted at ats 2009 SUNNYVALE, Calif., May 18 /PRNewswire/ -- Results of the Asthma I...l Thermoplasty System, developed by Asthmatx, Inc., were announced today at ats 2009, the International Conference of the American Thoracic Society, in San...

Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration

...ted at the American Thoracic Society (ATS) meeting in Toronto, Ontario. The ats presentations involved treprostinil delivered by inhaled, oral, intravenous...rapeutics will host an investor Q&A session following the conclusion of the ats conference at The Westin Harbour Castle, One Harbour Square, Toronto, Ontar...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

...lation Solution presented at International ats Conference -- NAPA, Calif., May 20 /PRNewswire/ ... dosing via nebulization." For those attending ats 2008, the presentation is available as follows: ...mptoms in COPD Patients The research presented at ats 2008 was supported through grants provided by Dey,...

Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD

... had a potent and long-lasting effect on preventing bronchoconstriction in both the human bronchi and several animal models assessed. Abstracts from ats 2008 will be available upon request. About Aclidinium Bromide Aclidinium bromide is a novel, inhaled anticholinergic bronchodilator that is curren...

More>>

ATS in Biological Technology

ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Dec. 8 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received FDA clearance for the marketing of the ATS 3f(R) Aortic Bioprosthesis that includes a new sewing t...

ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve

MINNEAPOLIS, July 9 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has obtained new in vivo data to support the outstanding wear characteristics of the ATS Open Pivot(R) Mecha...

ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve

MINNEAPOLIS, June 23 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced Health Canada -- Medical Device Bureau, Therapeutic Products Programme has approved use of the ATS Open Pivot(...

ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis

Follows Canadian regulatory approval of the ATS 3f Valve MINNEAPOLIS, April 10 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first North American commercial implant ...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

- Phase 3 CAPACITY results poster presentation Sunday, May 17, 8:15 a.m. PDT - - Phase 3 CAPACITY results oral presentation, Tuesday, May 19, 3:35 p.m. PDT - - Conference call and webcast Tuesday, May 19, 6 p.m. PDT - BRISBANE, Calif., May 14 /PRNewswire-FirstCall/ -- InterMun...

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.

...based Life Science Company announced today that at ats Labs using the required EPA protocol testing, BioN...nc., Dr. Andy Kielbania stated, "These independent ats Labs test results completely validate our internal...angerous and resilient C.diff microorganism. These ats lab results stand firmly on their own accord and w...

BioNeutral's Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms

...based Life Science company announced today that at ats Labs using the EPA required AOAC Sporicidal Test, ...ed: "These independent lab validation results from ats show that we have developed what we believe is the...ls well within those guidelines." About ats Labs: ...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase

...based Life Science company announced today that at ats Labs, using a Quantitative Disk Carrier test start...highly recognized independent laboratories such as ats Labs of Eagan, MN. In developing superior Ygiene(T...mand on the antimicrobial formulation. About ats Labs :...

Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care

...ypertension and non-invasive ventilation. Dr. Hill currently serves as ats secretary-treasurer and will serve as ats president from 2011 to 2012. Dr. Hill is a member of the Strategic Planning...

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

... MINNEAPOLIS, May 7 /PRNewswire-FirstCall/ -- ats Medical, Inc. (Nasdaq: ATSI ), manufacturer and ... Highlighting ATS's broad product offering is the ats 3f(R) Aortic Bioprosthesis designed to replace the patient's diseased valve. The ats 3f Aortic Bioprosthesis is a revolutionary next ge...

More>>